Selective adenosine A(2A) receptor inhibitor SCH58261 reduces oligodendrocyte loss upon brain injury in young rats

Cellular elements of maturing brain are vulnerable to insults, which lead to neurodevelopmental defects. There are no established treatments at present. Here we examined the efficacy of selective adenosine A(2A) receptor inhibitor SCH58261 to combat brain injury, particularly oligodendrocyte (OL) li...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Saudi J Biol Sci
Autores principales: Al-Griw, Mohamed A., Alghazeer, Rabia O., Awayn, Nuri, Shamlan, Ghalia, Eskandrani, Areej A., Alnajeebi, Afnan M., Babteen, Nouf A., Alansari, Wafa S.
Formato: Artigo
Lenguaje:Inglês
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7783643/
https://ncbi.nlm.nih.gov/pubmed/33424311
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.sjbs.2020.09.063
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares